- Risk of new strain of corona virus
- WHO green signal to Pfizer’s Kovid-19 vaccine
- Important step towards ensuring global reach of vaccine
The World Health Organization (WHO) on Thursday approved the emergency use of Pfizer and BioNotech’s Kovid-19 vaccine amidst the threat of a new COVID strain of the corona virus. This step of WHO has opened the way for countries around the world to allow the import and distribution of this vaccine soon. Britain first started its vaccination campaign on 8 December by approving the Pfizer vaccine. Later, the US, Canada and other European Union countries also allowed its use.
The World Health Organization stated that the Pfizer / BioNTech vaccine is the first vaccine that has been allowed for “emergency use” on its behalf after the corona virus pandemic unfolded.
“This is a very positive step towards ensuring the global reach of the COVID-19 vaccine worldwide,” said WHO senior officer Marianengela Simao. “In view of the need of the population around the world, a lot of effort is needed globally to ensure the availability of adequate amounts of vaccine,” he said in the statement.
The World Health Organization said its listing of the vaccine for emergency use has opened up avenues for regulators from different countries to allow the import and distribution of the vaccine.
The WHO reviewed the Pfizer vaccine’s ‘safety, efficacy and quality’ data from its own and worldwide experts and evaluated its advantages and disadvantages. It has been found in the review that this vaccine meets the standards set by the organization for safety and efficacy.
Video: All states will check preparations for Corona vaccination on January 2